+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Altimmune - logo

Altimmune is an immunotherapeutic biotechnology company that develops immunotherapeutic products and vaccines to address public health and biodefense needs. It offers NasoVAX, HepTcell, NasoShield and Oncosyn. The company also develops products for use in companion and commercial livestock and offers immunotherapeutic products for various disease indications. The company was founded in 1997 and is based in Gaithersburg, Maryland with operating sites in the UK and France.

Peptide Therapeutics: Contract API Manufacturing Market by Scale of Operation, Type of Synthesis Method Used, Company Size, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Peptide Therapeutics: Contract API Manufacturing Market by Scale of Operation, Type of Synthesis Method Used, Company Size, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • January 2022
  • 294 Pages
  • Global
From
Weight Loss/Weight Management (Obesity) - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Weight Loss/Weight Management (Obesity) - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • September 2022
  • 342 Pages
  • Global
From
Anthrax - Pipeline Insight, 2025 - Product Thumbnail Image

Anthrax - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Influenza A Virus H5N1 Subtype - Pipeline Insight, 2025 - Product Thumbnail Image

Influenza A Virus H5N1 Subtype - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Coronavirus (COVID-19) Current Therapy Global Market Report 2023 - Product Thumbnail Image

Coronavirus (COVID-19) Current Therapy Global Market Report 2023

  • Report
  • February 2023
  • 250 Pages
  • Global
From
Pandemic Influenza - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Pandemic Influenza - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • September 2021
  • 121 Pages
  • Global
From
Altimmune Inc (ALT:NAS): Financial Analysis, Benchmarks Against Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. - Product Thumbnail Image

Altimmune Inc (ALT:NAS): Financial Analysis, Benchmarks Against Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.

  • Company Profile
  • April 2025
  • 116 Pages
From
Comprehensive Report on Altimmune Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Altimmune Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Loading Indicator